Zdrowie i gospodarka · 14/07/1994
National Cancer Institute: Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Biomedical Use of Novel Approaches for HIV-1 Vaccine Development
The National Cancer Institute is seeking a pharmaceutical or biotechnology company to collaborate on a novel HIV-1 vaccine development approach through a Cooperative Research and Development Agreement (CRADA). This approach uses site-directed mutagenesis to reduce the antigenicity of immunodominant epitopes.
Source: Federal Register — Health and Human ServicesOpen original release →